Lumryz, a Single Dose Treatment Option for Narcolepsy, Now Available
Lumryz (sodium oxybate) is now available for the treatment of cataplexy or excessive daytime sleepiness in adults living with narcolepsy.
Source: empr.com
Page 7 - Wakefulness Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Wakefulness Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Wakefulness Test Today - Breaking & Trending Today
Suven Life Sciences : June 01, 2023Suven completed enrollment of patients to the phase-2(PoC) clinical study of SUVN-G3031 in US,CANADA
CSD/BSE&NSE/PR/2023-2024 June 1, 2023 To ... | June 1, 2023
Source: marketscreener.com
Pharmacologic Therapies Effective for Excessive Daytime Sleepiness
For patients with OSA, solriamfetol, armodafinil-modafinil, and pitolisant reduce daytime sleepiness, with solriamfetol likely superior.
Source: neurologyadvisor.com
FDA Approves Once-Nightly Lumryz for Patients With Narcolepsy
The FDA has granted final approval to Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.
Source: neurologyadvisor.com
Pharmacologic Therapies Effective for Excessive Daytime Sleepiness
WEDNESDAY, May 10, 2023 (HealthDay News) -- For patients with obstructive sleep apnea (OSA), solriamfetol, armodafinil-modafinil, and pitolisant reduce daytime sleepiness, with solriamfetol likely superior, according to a systematic review
Source: vtcng.com